Literature DB >> 6426922

Current status of disease-modifying drugs in progressive rheumatoid arthritis.

J D O'Duffy, H S Luthra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6426922     DOI： 10.2165/00003495-198427050-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  33 in total

1.  Intra-articular dissociation of the rheumatoid factor.

Authors:  I A JAFFE
Journal:  J Lab Clin Med       Date:  1962-09

2.  Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.

Authors: 
Journal:  Lancet       Date:  1973-02-10       Impact factor: 79.321

3.  Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis.

Authors:  T W Bunch; J D O'Duffy; R B Tompkins; W M O'Fallon
Journal:  Arthritis Rheum       Date:  1984-03

Review 4.  Disease-modifying drugs for progressive rheumatoid arthritis.

Authors:  T W Bunch; J D O'Duffy
Journal:  Mayo Clin Proc       Date:  1980-03       Impact factor: 7.616

5.  Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.

Authors:  J P Gofton; W M O'Brien
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

6.  Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.

Authors:  K Bandilla; D Gross; W Gross; J D Herrlinger; W Kriegel; W Müller; W Siegmeth; G Tausch; N Thumb; F J Wagenhäuser
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

7.  Auranofin and lysosomal enzymes.

Authors:  A E Finkelstein; F R Roisman; M G Ladizesky; D T Walz
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

8.  The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.

Authors:  W A Katz; S Alexander; J H Bland; W Blechman; G B Bluhm; R A Bonebrake; A Falbo; R A Greenwald; S Hartman; T Hobbs; S Indenbaum; J E Lergier; B G Lanier; R W Lightfoot; P Phelps; R P Sheon; D Torretti; M E Wenger; K Wilske
Journal:  J Rheumatol Suppl       Date:  1982 Jul-Aug

9.  Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.

Authors:  D J McCarty; G F Carrera
Journal:  JAMA       Date:  1982-10-08       Impact factor: 56.272

10.  Clinical trial of penicillamine in rheumatoid arthritis.

Authors:  N O Rothermich; M H Thomas; V K Phillips; W Bergen
Journal:  Arthritis Rheum       Date:  1981-12
View more
  3 in total

1.  A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation.

Authors:  K M Bottomley; R J Griffiths; T J Rising; A Steward
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

2.  Cross-sectional study of rheumatoid arthritis treatment in a university hospital.

Authors:  W T Friesen; Y A Hekster; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

3.  Clinical efficacy of Rasona Pinda in the management of Amavata (rheumatoid arthritis).

Authors:  Jai Prakash Singh; Meera Antiwal; Amit Vaibhav; J S Tripathi; S K Tiwari
Journal:  Ayu       Date:  2010-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.